Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.8223 USD | -2.35% | +10.14% | -59.69% |
May. 09 | Earnings Flash (GRTS) GRITSTONE BIO Posts Q1 Revenue $1.74M, vs. Street Est of $2.85M | MT |
May. 09 | Transcript : Gritstone bio, Inc., Q1 2024 Earnings Call, May 09, 2024 |
Chart calendar Gritstone bio, Inc.
Upcoming events on Gritstone bio, Inc.
Past events on Gritstone bio, Inc.
2024-05-14 10:30 am | Citizens JMP Life Sciences Conference - Fireside Chat |
2024-05-13 09:00 am | PEGS Boston Conference - Panel |
2024-05-09 04:30 pm | Q1 2024 Earnings Call |
2024-05-09 04:05 pm | Q1 2024 Earnings Release |
2024-04-30 06:30 am | Neoantigen International Summit |
2024-04-24 04:05 am | Cambridge Healthtech Institute Immuno-Oncology Summit |
2024-04-15 11:00 am | CG Horizons in Oncology Virtual Conference - Panel |
2024-04-09 11:00 am | Needham Virtual Healthcare Conference |
2024-04-08 03:00 pm | American Association for Cancer Research Meeting - Abstract 904 |
2024-04-03 09:10 am | World Vaccine Congress - Panel |
2024-03-05 04:05 pm | Q4 2023 Earnings Release |
2024-03-04 10:30 am | TD Cowen Health Care Conference - Panel |
2024-02-27 02:30 pm | IO360 Summit - Panel |
2024-02-26 02:00 pm | BIO Ceo & Investor Conference - Panel |
2024-01-18 01:30 pm | B. Riley Securities Oncology Conference - Track 2 |
2023-12-05 11:00 am | Goldman Sachs Catalyst Clinic Meeting |
2023-11-30 10:00 am | Piper Sandler Healthcare Conference |
2023-11-29 10:00 am | Evercore ISI HealthCONx Conference |
2023-11-08 04:05 pm | Q3 2023 Earnings Release |
2023-10-17 06:00 pm | BIO Investor Forum |
Annual results
Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 4,37 4,56 -4.35% | 4,04 3,89 3.73% | 48,2 48,0 0.39% | 19,9 18,6 7.3% | 16,3 11,1 46.74% | 15,5 |
EBITDA Million USD | Released Forecast Spread | -93,2 -93,5 0.33% | -99,4 -103 3.13% | -68,9 -65,8 -4.72% | -114 -113 -0.46% | -132 -139 5.19% | -161 |
EBIT Million USD | Released Forecast Spread | -97,9 -95,4 -2.63% | -106 -107 0.58% | -75,2 -73,7 -2.07% | -120 -120 -0.56% | -140 -146 4.31% | -135 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -94,4 -93,0 -1.53% | -105 -105 -0.25% | -75,1 -73,9 -1.55% | -120 -120 -0.08% | -138 -145 4.2% | -131 |
Net income Million USD | Released Forecast Spread | -94,4 -93,0 -1.53% | -105 -105 -0.25% | -75,1 -73,9 -1.55% | -120 -120 -0.08% | -138 -145 4.2% | -134 |
EPS USD | Released Forecast Spread | -2,81 -2,63 -6.71% | -2,79 -2,71 -2.83% | -0,95 -1,08 12.04% | -1,32 -1,42 6.71% | -1,20 -1,29 7.18% | -1,01 |
Announcement Date | 11/03/20 | 11/03/21 | 10/03/22 | 09/03/23 | 05/03/24 | - |
Quarterly results
Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 7,19 4,21 70.71% | 5,47 3,19 71.38% | 3,02 3,61 -16.27% | 4,26 2,90 46.83% | 2,44 3,17 -22.85% | 1,96 2,47 -20.79% | 1,57 2,21 -29.17% | 10,4 5,11 103.07% | 1,74 2,85 -38.94% | 1,41 | 11,7 | 15,4 | 75,5 | 60,5 |
EBIT Million USD | Released Forecast Spread | -29,0 -30,5 5.18% | -29,7 -31,3 5.18% | -29,9 -32,0 6.77% | -31,9 -31,3 -2.12% | -34,8 -33,6 -3.54% | -35,7 -35,6 -0.35% | -38,6 -36,4 -6.16% | -30,5 -35,0 12.94% | -39,8 -35,7 -11.35% | -39,3 | -33,6 | -32,3 | -29,0 | -29,5 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -28,9 -30,5 5.19% | -29,5 -31,6 6.56% | -30,0 -31,6 5.2% | -31,3 -31,2 -0.24% | -34,0 -32,9 -3.29% | -35,3 -35,4 0.3% | -38,4 -37,4 -2.67% | -30,8 -36,7 16.08% | -40,4 -35,1 -15.11% | -39,7 | -30,8 | -29,0 | -30,3 | -31,0 |
Net income Million USD | Released Forecast Spread | -28,9 -30,5 5.19% | -29,5 -31,6 6.56% | -30,0 -31,6 5.2% | -31,3 -31,2 -0.24% | -34,0 -32,9 -3.29% | -35,3 -35,4 0.3% | -38,4 -37,4 -2.67% | -30,8 -36,7 16.08% | -40,4 -35,1 -15.11% | -39,7 | -30,8 | -29,0 | -30,3 | -31,0 |
EPS USD | Released Forecast Spread | -0,34 -0,36 5.56% | -0,34 -0,41 17.07% | -0,35 -0,40 11.95% | -0,30 -0,35 14.89% | -0,30 -0,34 11.76% | -0,31 -0,36 12.92% | -0,33 -0,36 7.3% | -0,26 -0,33 20.87% | -0,34 -0,32 -5.31% | -0,31 | -0,22 | -0,21 | -0,22 | -0,22 |
Announcement Date | 05/05/22 | 04/08/22 | 03/11/22 | 09/03/23 | 11/05/23 | 09/08/23 | 08/11/23 | 05/03/24 | 09/05/24 | - | - | - | - | - |
2024-07-11 02:00 am | BONESUPPORT HOLDING AB: Q2 2024 Earnings Release |
2024-07-15 | SWEDISH ORPHAN BIOVITRUM AB: Q2 2024 Earnings Release |
2024-07-22 | BIOGEN INC.: Q2 2024 Earnings Release (Projected) |
2024-07-23 02:00 am | BIOGAIA AB: Q2 2024 Earnings Release |
2024-07-23 | SAMSUNG BIOLOGICS CO.,LTD.: Q2 2024 Earnings Release (Projected) |
2024-07-24 | PHARMA MAR, S.A.: Q2 2024 Earnings Release (Projected) |
2024-07-24 | GRIFOLS, S.A.: Q2 2024 Earnings Release (Projected) |
2024-07-25 01:00 am | UCB: Q2 2024 Earnings Release |
2024-07-25 | SK BIOSCIENCE CO.,LTD.: Q2 2024 Earnings Release (Projected) |
2024-07-29 | BIOMARIN PHARMACEUTICAL INC.: Q2 2024 Earnings Release (Projected) |
Past sector events for Gritstone bio, Inc.
2024-05-22 | CONCORD BIOTECH LIMITED: Q4 2024 Earnings Release |
2024-05-14 11:35 am | GRIFOLS, S.A.: Q1 2024 Earnings Release |
2024-05-12 | ALTEOGEN INC.: Q1 2024 Earnings Release (Projected) |
2024-05-09 | PHARMARESEARCH CO., LTD.: Q1 2024 Earnings Release |
2024-05-09 | MEDY-TOX INC.: Q1 2024 Earnings Release |
2024-05-09 04:05 pm | AVIDITY BIOSCIENCES, INC.: Q1 2024 Earnings Release |
2024-05-09 04:05 pm | ADMA BIOLOGICS, INC.: Q1 2024 Earnings Release |
2024-05-09 02:30 am | NXERA PHARMA CO., LTD.: Q1 2024 Earnings Release |
2024-05-08 | HUGEL, INC.: Q1 2024 Earnings Release |
2024-05-08 04:16 pm | CATALYST PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- GRTS Stock
- Calendar Gritstone bio, Inc.